5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer
    Journal Article

    Slovin, S. F.; Kehoe, M.; Durso, R.; Fernandez, C.; Olson, W.; Gao, J. P.; Israel, R.; Scher, H. I.; Morris, S.
    Vaccine (2013)

    Fulltext@MSK | Save
  • Abiraterone in metastatic prostate cancer without previous chemotherapy
    Journal Article

    Ryan, C. J.; Smith, M. R.; de Bono, J. S.; Molina, A.; Logothetis, C. J.; De Souza, P.; Fizazi, K.; Mainwaring, P.; Piulats, J. M.; Ng, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: A 1H MRS study
    Journal Article

    Qi, J.; Fong, Y.; Saltz, L.; D'Angelica, M. I.; Kemeny, N. E.; Gonen, M.; Shia, J.; Shukla-Dave, A.; Jarnagin, W.; Do, R. K. G.; more...
    NMR in Biomedicine (2013)

    Fulltext@MSK | Save
  • The conundrum of clinical trials in adult germ-cell tumours
    Journal Article

    Powles, T.; Kollmannsberger, C.; Feldman, D. R.
    Lancet Oncology (2013)

    Fulltext@MSK | Save
  • Response of HT29 colorectal xenograft model to cediranib assessed with 18F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI
    Journal Article

    Bokacheva, L.; Kotedia, K.; Reese, M.; Ricketts, S. A.; Halliday, J.; Le, C. H.; Koutcher, J. A.; Carlin, S.
    NMR in Biomedicine (2013)

    Fulltext@MSK | Save
  • ICUD-EAU international consultation on bladder cancer 2012: Chemotherapy for urothelial carcinoma - Neoadjuvant and adjuvant settings
    Journal Article

    Sternberg, C. N.; Bellmunt, J.; Sonpavde, G.; Siefker-Radtke, A. O.; Stadler, W. M.; Bajorin, D. F.; Dreicer, R.; George, D. J.; Milowsky, M. I.; Theodorescu, D.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration- resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Yu, C.; Kattan, M. W.; Hutson, T. E.; Hudes, G. R.; Yuan, J.; Valota, O.; Motzer, R. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Scott, S. N.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The impact of prior therapy with ketoconazole (keto) on clinical outcomes after subsequent docetaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) patients: Results from a randomized phase III trial (CALGB 90401)
    Meeting Abstract

    Small, E. J.; Halabi, S.; Carducci, M. A.; Ryan, C. J.; George, D. J.; Mahoney, J. F.; Stadler, W. M.; Morris, M. J.; Kantoff, P.; Monk, J. P.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save